Valion Bio says IACUC clears AFRRI-run Entolimod radiation-injury study in mice

Reuters2026/08/12 15:29

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Valion Bio disclosed a U.S. government-funded AFRRI/NIAID program evaluating Entolimod for lethal radiation-induced gastrointestinal injury.
IACUC approval secured for the AFRRI mouse studies; a safety study is set to start this week.
Therapeutic study to follow, with top-line data expected in early fall.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Valion Bio says IACUC clears AFRRI-run Entolimod radiation-injury study in mice

You may also like

Crypto prices